High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: Long-term survival update

Journal of Clinical Oncology

Volumn 24, Issue 18, 2006, Pages 2891-2896

  George, Rani E ^a   Li, Shuli ^a   Medeiros Nancarrow, Cheryl ^a   Neuberg, Donna ^a   Marcus, Karen ^a   Shamberger, Robert C ^a   Pulsipher, Michael ^a   Grupp, Stephan A ^a   Diller, Lisa ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION; AUTOTRANSPLANTATION; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; SECOND CANCER; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; HUMANS; INFANT; NEOPLASMS, SECOND PRIMARY; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 33745528137     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.05.6986     Document Type: Article

References (33)

1. Philip T, Zucker JM, Bernard JL, et al: Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 9:1037-1044, 1991
2. Kushner BH, O'Reilly RJ, Mandell LR, et al: Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 9:274-279, 1991
3. Ladenstein R, Philip T, Lasset C, et al: Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: A report from the European Bone Marrow Transplantation Solid Tumor Registry. J Clin Oncol 16:953-965, 1998
4. Matthay KK, Villablanca JG, Seeger RC, et al: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid: Children's Cancer Group. N Engl J Med 341:1165-1173, 1999
5. Frappaz D, Michon J, Coze C, et al: LMCE3 treatment strategy: Results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. J Clin Oncol 18:468-476, 2000
6. Kramer K, Kushner B, Heller G, et al: Neuroblastoma metastatic to the central nervous system: The Memorial Sloan-Kettering Cancer Center Experience and A Literature Review. Cancer 91:1510-1519, 2001
7. Choi HS, Koh SH, Park ES, et al: CNS recurrence following CD34+ peripheral blood stem cell transplantation in stage 4 neuroblastoma. Pediatr Blood Cancer 45:68-71, 2005
8. Grupp SA, Stern JW, Bunin N, et al: Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 18:2567-2575, 2000
9. Grupp SA, Stern JW, Bunin N, et al: Rapid-sequence tandem transplant for children with high-risk neuroblastoma. Med Pediatr Oncol 35:696-700, 2000
10. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
11. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
12. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
14. Philip T, Ladenstein R, Zucker JM, et al: Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: The LMCE2 study. Br J Cancer 67:119-127, 1993
15. Kletzel M, Katzenstein HM, Haut PR, et al: Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: Results of the Chicago Pilot II Study. J Clin Oncol 20:2284-2292, 2002
16. Castleberry RP, Cantor AB, Green AA, et al: Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 12:1616-1620, 1994
17. Kretschmar CS, Kletzel M, Murray K, et al: Response to paclitaxel, topotecan, and topotecancyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: A Pediatric Oncology Group study. J Clin Oncol 22:4119-4126, 2004
18. Marcus KJ, Shamberger R, Litman H, et al: Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol 25:934-940, 2003
19. Haas-Kogan DA, Swift PS, Selch M, et al: Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study. Int J Radiat Oncol Biol Phys 56:28-39, 2003
20. von Allmen D, Grupp S, Diller L, et al: Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 40:936-941, 2005
21. Sirohi B, Powles R, Kulkarni S, et al: Reassessing autotransplantation for acute myeloid leukaemia in first remission: A matched pair analysis of autologous marrow vs. peripheral blood stem cells. Bone Marrow Transplant 33:1209-1214, 2004
22. Matthay KK, Brisse H, Couanet D, et al: Central nervous system metastases in neuroblastoma: Radiologic, clinical, and biologic features in 23 patients. Cancer 98:155-165, 2003
23. Carpentieri SC, Diller LR: Neuropsychological resiliency after treatment for advanced stage neuroblastoma. Bone Marrow Transplant 35:1117-1122, 2005
24. Kushner BH, Cheung NK, Kramer K, et al: Neuroblastoma and treatment-related myelodysplasia/leukemia: The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol 16:3880-3889, 1998
25. Andersen MK, Larson RA, Mauritzson N, et al: Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop. Genes Chromosomes Cancer 33:395-400, 2002
26. Rubino C, Adjadj E, Guerin S, et al: Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment. Int J Cancer 107:791-796, 2003
27. Tucker MA, Jones PH, Boice JD Jr, et al: Therapeutic radiation at a young age is linked to secondary thyroid cancer: The Late Effects Study Group. Cancer Res 51:2885-2888, 1991
28. de Vathaire F, Hawkins M, Campbell S, et al: Second malignant neoplasms after a first cancer in childhood: Temporal pattern of risk according to type of treatment. Br J Cancer 79:1884-1893, 1999
29. Matthay KK, Edeline V, Lumbroso J, et al: Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol 21:2486-2491, 2003
30. Bowman LC, Hancock ML, Santana VM, et al: Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: The St Jude Children's Research Hospital experience, 1962 to 1988. J Clin Oncol 9:1599-1608, 1991
31. Cotterill SJ, Pearson AD, Pritchard J, et al: Clinical prognostic factors in 1277 patients with neuroblastoma: Results of the European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer 36:901-908, 2000
32. Stram DO, Matthay KK, O'Leary M, et al: Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group studies. J Clin Oncol 14:2417-2426, 1996
33. Berthold F, Hero B: Neuroblastoma: Current drug therapy recommendations as part of the total treatment approach. Drugs 59:1261-1277, 2000